Trials / Sponsors / Karen Carty
Karen Carty
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | A Trial of Gemcitabine, Pembrolizumab and IMM-101 as First Line Treatment in Patients With Metastatic Pancreat Neoplasms Pancreatic | Phase 2 | 2024-06-17 |